Biotech

All Articles

ArsenalBio increases $325M, rotates far from former lead asset

.Collection Biosciences is actually moving on up. The tissue treatment company has added $325 thousa...

Lilly- supported fat loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' marijuana use drug fails stage 2b, steering Indivior to re-think $100M choice

.Aelis Farma's hopes of safeguarding an easy, positive selection on a $100 million option remittance...

ProKidney stops stage 3 trial not required for cell treatment confirmation

.ProKidney has actually ceased among a set of phase 3 tests for its own cell therapy for kidney illn...

Vaxcyte surges on 'impressive' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what analysts referred to as "stunning" period 1/2 information for its own 31-vale...

Recursion's mind disease trial presents insufficient documentation of effectiveness

.Recursion has actually stumbled via a very early exam of its tech-enabled technique to medicine rev...

Acepodia, Pfizer click with each other for chemistry-based tissue therapy

.Call it a case of good chemistry: Acepodia, a biotech based upon Nobel Champion science, is actuall...

Praxis epilepsy drug reduces seizures in period 2 hearing

.Practice Preciseness Medicines has scored an additional midphase gain in epilepsy this year, along ...

Three directors surrender as Dyne messages combined data for DMD prospect

.After getting away a clinical hold many years back, Dyne Rehab has disclosed brand-new period 1/2 r...

Arrowhead fires off period 3 records in rare metabolic illness in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its give ahead of a possible face-off with Ionis, rele...